Overexpression of CDC25B and LAMC2 mRNA and protein in esophageal squamous cell carcinomas and premalignant lesions in subjects from a high-risk population in China

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 6, 2008, Pages 1424-1435

  Shou, Jian Zhong ^a   Hu, Nan ^b   Takikita, Mikiko ^b   Roth, Mark J ^b   Johnson, Laura Lee ^c   Giffen, Carol ^d   Wang, Quan Hong ^e   Wang, Chaoyu ^b   Wang, Yuan ^e   Su, Hua ^b   Kong, Li Hui ^e   Emmert Buck, Michael R ^b   Goldstein, Alisa M ^b   Hewitt, Stephen M ^b   Taylor, Philip R ^b  

^a CANCER HOSPITAL   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

^e SHANXI CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CDC25B PROTEIN; LAMC2 PROTEIN; LAMININ; MESSENGER RNA; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CHINA; DYSPLASIA; EARLY DIAGNOSIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS BIOPSY; FAMILY HISTORY; FEMALE; GENE OVEREXPRESSION; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIFESTYLE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; TISSUE MICROARRAY; TUMOR DIFFERENTIATION;

CARCINOMA, SQUAMOUS CELL; CDC25 PHOSPHATASES; CHINA; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; LAMININ; LINEAR MODELS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROPORTIONAL HAZARDS MODELS; PROTEIN ARRAY ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 53349163553     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0666     Document Type: Article

References (48)

1. National Cancer Control Office. Investigation of cancer mortality in China. People's Health Publishing House, Beijing, China 1980.
2. Li JY. Epidemiology of esophageal cancer in China. Natl Cancer Inst Monogr 1982;62:113-20.
3. Su H, Hu N, Shih J, et al. Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer. Cancer Res 2003;63:3872-6.
4. Galaktionov K, Beach D. Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins. Cell 1991;67:1181-94.
5. Demetrick DJ, Beach DH. Chromosome mapping of human CDC25A and CDC25B phosphatases. Genomics 1993;18:144-7.
6. Galaktionov K, Lee AK, Eckstein J, Draetta G, Meckler J, Loda M. Beach D. CDC25 phosphatases as potential human oncogenes. Science 1995;269:1575-7.
7. Hernandez S, Hernandez L, Bea S, et al. cdc25a and the splicing variant CDC25B2, but not CDC25B1, -B3 or -C, are over-expressed in aggressive human non-Hodgkin's lymphomas. Int J Cancer 2000;89:148-52.
8. Miyata H, Doki Y, Shiozaki H, et al. CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers. Clin Cancer Res 2000;6:4859-65.
9. Takemasa I, Yamamoto H, Sekimoto M, et al. Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma. Cancer Res 2000;60:3043-50.
10. Sato Y, Sasaki H, Kondo S, et al. Expression of the CDC25B mRNA correlated with that of N-myc in neuroblastoma. Jpn J Clin Oncol 2001;31:428-31.
11. Sasaki H, Sato Y, Kondo S, et al. Expression of the prothymosin α mRNA correlated with that of N-myc in neuroblastoma. Cancer Lett 2001;168:191-5.
12. Hu YC, Lam KY, Law S, Wong J, Srivastava G. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res 2001;7:2213-21.
13. 2-M arrest and results in increased apoptosis in esophageal cancer cells. Cancer Res 2001;61:3188-93.
14. Hernandez S, Bessa X, Bea S, et al. Differential expression of cdc25 cell-cycle-activating phosphatases in human colorectal carcinoma. LabInvest 2001;81:465-73.
15. Nishioka K, Doki Y, Shiozaki H, et al. Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus. Br J Cancer 2001;85:412-21.
16. Kishi K, Doki Y, Miyata H, Yano M, Yasuda T, Monden M. Prediction of the response to chemoradiation and prognosis in oesophageal squamous cancer. Br J Surg 2002;89:597-603.
17. Ito Y, Yoshida H, Nakano K, et al. Expression of cdc25A and CDC25B proteins in thyroid neoplasms. Br J Cancer 2002;86:1909-13.
18. Xu X, Yamamoto H, Sakon M, et al. Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas. Clin Cancer Res 2003;9:1764-72.
19. Ngan ES, Hashimoto Y, Ma ZQ, Tsai MJ, Tsai SY. Overexpression of CDC25B, an androgen receptor coactivator, in prostate cancer. Oncogene 2003;22:734-9.
20. Wu W, Slomovitz BM, Celestino J, Chung L, Thornton A, Lu KH. Coordinate expression of CDC25B and ER-α is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas. Cancer Res 2003;63:6195-9.
21. Kallunki P, Sainio K, Eddy R, et al. A truncated laminin chain homologous to the B2 chain: structure, spatial expression, and chromosomal assignment. J Cell Biol 1992;119:679-93.
22. Burgeson RE, Chiquet M, Deutzmann R, et al. A new nomenclature for the laminins. Matrix Biol 1994;14:209-11.
23. Baker SE, DiPasquale AP, Stock EL, Quaranta V, Fitchmun M, Jones JC. Morphogenetic effects of soluble laminin-5 on cultured epithelial cells and tissue explants. Exp Cell Res 1996;228:262-70.
24. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997;277:225-8.
25. Yamamoto H, Itoh F, Iku S, Hosokawa M, Imai K. Expression of the γ(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Clin Cancer Res 2001;7:896-900.
26. Koshikawa N, Moriyama K, Takamura H, et al. Overexpression of laminin γ2 chain monomer in invading gastric carcinoma cells. Cancer Res 1999;59:5596-601.
27. Lohi J. Laminin-5 in the progression of carcinomas. Int J Cancer 2001;94:763-7.
28. Skyldberg B, Salo S, Eriksson E, et al. Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst 1999;91:1882-7.
29. Applied Biosystems. Relative quantitation of gene expression. User Bulletin No. 2. ABI Prism 7700 Sequence Detection System. Foster City (CA): Applied Biosystems; 1997.
30. Ginzinger DG. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 2002;30:503-12.
31. Livak MJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-CT) method. Methods 2001;25:402-8.
32. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-7.
33. Kuratomi Y, Kumamoto M, Kidera K, et al. Diffuse expression of laminin γ2 chain in disseminating and infiltrating cancer cells indicates a highly malignant state in advanced tongue cancer. Oral Oncol 2006;42:73-6.
34. Nakamura T, Hayashi K, Ota M, Ide H, Takasaki K, Mitsuhashi M. Expression of p21(Waf1/Cip1) predicts response and survival of esophageal cancer patients treated by chemoradiotherapy. Dis Esophagus 2004;17:315-21.
35. Xue LY, Hu N, Song YM, et al. Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma. BMC Cancer 2006;6:296.
36. Mailand N, Falck J, Lukas C, et al. Rapid destruction of human Cdc25A in response to DNA damage. Science 2000;288:1425-9.
37. Sanchez Y, Wong C, Thoma RS, et al. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 1997;277:1497-501.
38. Gabrielli BG, De Souza CP, Tonks ID, Clark JM, Hayward NK, Ellem KA. Cytoplasmic accumulation of CDC25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. J Cell Sci 1996;109:1081-93.
39. Yao Y, Slosberg ED, Wang L, et al. Increased susceptibility to carcinogen-induced mammary tumors in MMTV-CDC25B transgenic mice. Oncogene 1999;18:5159-66.
40. Sasaki H, Yukiue H, Kobayashi Y, et al. Expression of the CDC25B gene as a prognosis marker in non-small cell lung cancer. Cancer Lett 2001;173:187-92.
41. Broggini M, Buraggi G, Brenna A, et al. Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients. Anticancer Res 2000;20:4835-40.
42. Hashiguchi Y, Tsuda H, Inoue T, Nishimura S, Suzuki T, Kawamura N. Alteration of cell cycle regulators correlates with survival in epithelial ovarian cancer patients. Hum Pathol 2004;35:165-75.
43. Cangi MG, Cukor B, Soung P, et al. Role of the Cdc25A phosphatase in human breast cancer. J Clin Invest 2000;106:753-61.
44. Ito Y, Yoshida H, Uruno T, et al. Expression of cdc25A and CDC25B phosphatase in breast carcinoma. Breast Cancer 2004;11:295-300.
45. Henning K, Berndt A, Katenkamp D, Kosmehl H. Loss of laminin-5 in the epithelium-stroma interface: an immunohistochemical marker of malignancy in epithelial lesions of the breast. Histopathology 1999;34:305-9.
46. Hao J, Jackson L, Calaluce R, McDaniel K, Dalkin BL, Nagle RB. Investigation into the mechanism of the loss of laminin 5 (α3β 3γ2) expression in prostate cancer. Am J Pathol 2001;158:1129-35.
47. Mori M, Shimono R, Kido A, Kuwano H, Akazawa K, Sugimachi K. Distribution of basement membrane antigens in human esophageal lesions: an immunohistochemical study. Int J Cancer 1991;47:839-42.
48. Fukai Y, Masuda N, Kato H, et al. Correlation between laminin-5 γ2 chain and epidermal growth factor receptor expression in esophageal squamous cell carcinomas. Oncology 2005;69:71-80.